AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

PLUS THERAPEUTICS, INC. Director's Dealing 2014

Jan 14, 2014

34301_dirs_2014-01-14_3ffc8edb-d701-441f-afa7-bae91c098882.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2014-01-10

Reporting Person: CALHOUN CHRISTOPHER J (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-10	Common Stock	S	500	$2.81	Disposed	146770	Direct
2014-01-10	Common Stock	S	2600	$2.82	Disposed	144170	Direct
2014-01-10	Common Stock	S	1200	$2.83	Disposed	142970	Direct
2014-01-10	Common Stock	S	700	$2.84	Disposed	142270	Direct
2014-01-10	Common Stock	S	600	$600	Disposed	141670	Direct
2014-01-10	Common Stock	S	1200	$2.86	Disposed	140470	Direct
2014-01-10	Common Stock	S	900	$2.87	Disposed	139570	Direct
2014-01-10	Common Stock	S	2300	$2.88	Disposed	137270	Direct
2014-01-10	Common Stock	S	3399	$2.89	Disposed	133871	Direct
2014-01-10	Common Stock	S	400	$2.90	Disposed	133471	Direct
2014-01-10	Common Stock	S	2100	$2.92	Disposed	131371	Direct
2014-01-10	Common Stock	S	5803	$2.93	Disposed	125568	Direct
2014-01-10	Common Stock	S	4043	$2.94	Disposed	121525	Direct
2014-01-10	Common Stock	S	1400	$2.95	Disposed	120125	Direct
2014-01-10	Common Stock	S	2000	$2.96	Disposed	118125	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	36850	Indirect

Footnotes

F1: Shares sold pursuant to a 10b5-1 Plan.